Curis Announces Positive Emavusertib Update

Data ReadoutpositiveemavusertibPositive

AI Analysis

Summary

Curis announced positive clinical data updates for emavusertib in PCNSL and increased its guidance for year-end data in CLL. The company will host a webcast to discuss the updates.

Clinical Trial Data

Outcome Details

Positive clinical data update in PCNSL; increased guidance on year-end data in CLL

Importance:6/10

Sentiment:

0.70

emavusertibPCNSLCLLclinical datadata update

Related Companies

$CRIS

Read the original article

Published by PR Newswire Biotech on July 22, 2026 11:00 AM

Read Original